| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Full Paper |
1 1st Department of Internal Medicine, Caritas Hospital Bad Mergentheim, Uhlandstr. 7, 97980 Bad Mergentheim, 2 2nd Department of Internal Medicine and 3 Senckenberg Center of Pathology, Johann Wolfgang Goethe University, Theodor Stern Kai 7, D-60590 Frankfurt am Main, Germany
Non-invasive differentiation of focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA) is difficult. The aim of this study was to assess the accuracy of contrast-enhanced phase inversion ultrasound to differentiate between histologically proven FNH and HCA, analysing the arterial and (early) portal venous phase. 32 patients with histological proven FNH (n=24) or HCA (n=8) have been included in this prospective study. Examination technique: Siemens Elegra, phase inversion harmonic imaging (PIHI) with low mechanical index (MI)<0.2–0.3 using SonoVue® (BR 1). The contrast enhancing tumour characteristics were evaluated during the hepatic arterial (starting 8–22 s) and early portal venous phase (starting 12–30 s). The image analysis was performed by three examiners. In 23 of 24 patients with FNH the contrast pattern revealed pronounced arterial and (early) portal venous enhancement. Homogeneous enhancement was detected during the hepatic arterial phase in all eight patients with HCA. In contrast to patients with FNH, no enhancement was seen during the portal venous phase. In conclusion, contrast-enhanced phase inversion ultrasound demonstrated pronounced arterial and portal venous enhancement in patients with focal nodular hyperplasia. In contrast, after homogeneous enhancement during hepatic arterial phase, no enhancement during hepatic portal venous phase was detected in patients with hepatocellular adenoma. Therefore, this technique might improve the functional characterization of benign hypervascular focal liver lesions.
This article has been cited by other articles:
 |
|
 |
|
  S. R. Wilson, L. D. Greenbaum, and B. B. Goldberg Contrast-Enhanced Ultrasound: What Is the Evidence and What Are the Obstacles? Am. J. Roentgenol., July 1, 2009; 193(1): 55 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. von Herbay, A.-P. Barreiros, A. Ignee, J. Westendorff, M. Gregor, P. R. Galle, and C. Dietrich Contrast-Enhanced Ultrasonography With SonoVue: Differentiation Between Benign and Malignant Lesions of the Spleen J. Ultrasound Med., April 1, 2009; 28(4): 421 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. T. Nguyen, A. Bressenot, S. Manole, M. A. Galloy, J. P. Bronowicki, M. Vidailhet, F. Feillet, and M. Claudon Contrast-Enhanced Ultrasonography in Patients With Glycogen Storage Disease Type Ia and Adenomas J. Ultrasound Med., April 1, 2009; 28(4): 497 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Ricci, V. Cantisani, M. D'Onofrio, D. Sahani, E. Pagliara, F. Calliada, E. Mehmet, K. Sanjeva, N. Faccioli, R. Pozzi-Mucelli, et al. Behavior of Hepatocellular Adenoma on Real-time Low-Mechanical Index Contrast-Enhanced Ultrasonography With a Second-Generation Contrast Agent J. Ultrasound Med., December 1, 2008; 27(12): 1719 - 1726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Wilson, H.-J. Jang, T. K. Kim, H. Iijima, N. Kamiyama, and P. N. Burns Real-Time Temporal Maximum-Intensity-Projection Imaging of Hepatic Lesions with Contrast-Enhanced Sonography Am. J. Roentgenol., March 1, 2008; 190(3): 691 - 695. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Kim, H.-J. Jang, P. N. Burns, J. Murphy-Lavallee, and S. R. Wilson Focal Nodular Hyperplasia and Hepatic Adenoma: Differentiation with Low-Mechanical-Index Contrast-Enhanced Sonography Am. J. Roentgenol., January 1, 2008; 190(1): 58 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 BJR Review of the Year - 2005. Br. J. Radiol., March 1, 2006; 79(939): 183 - 187. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| BJR | DMFR | IMAGING | ALL BIR JOURNALS |
